Interferon Alfa, Isotretinoin, and Paclitaxel in Treating Patients With Recurrent Small Cell Lung Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Joseph Aisner, MD
Rutgers Cancer Institute of New Jersey
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
73 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Veterans Affairs Medical Center - Atlanta (decatur)
Decatur, Georgia, United States
- Rush-Copley Cancer Care Center
Aurora, Illinois, United States
- Hinsdale Hematology Oncology Associates
Hinsdale, Illinois, United States
- Joliet Oncology-Hematology Associates, Limited - West
Joliet, Illinois, United States
- Swedish-American Regional Cancer Center
Rockford, Illinois, United States
- Ccop - Carle Cancer Center
Urbana, Illinois, United States
- Carle Cancer Center at Carle Foundation Hospital
Urbana, Illinois, United States
- Elkhart General Hospital
Elkhart, Indiana, United States
- Howard Community Hospital
Kokomo, Indiana, United States
- Center for Cancer Therapy at Laporte Hospital and Health Services
La Porte, Indiana, United States
- Saint Anthony Memorial Health Centers
Michigan City, Indiana, United States
- Ccop - Northern Indiana Cr Consortium
South Bend, Indiana, United States
- Memorial Hospital of South Bend
South Bend, Indiana, United States
- Saint Joseph Regional Medical Center
South Bend, Indiana, United States
- Ccop - Iowa Oncology Research Association
Des Moines, Iowa, United States
- John Stoddard Cancer Center at Iowa Lutheran Hospital
Des Moines, Iowa, United States
- John Stoddard Cancer Center at Iowa Methodist Medical Center
Des Moines, Iowa, United States
- Medical Oncology and Hematology Associates at John Stoddard Cancer Center
Des Moines, Iowa, United States
- Medical Oncology and Hematology Associates at Mercy Cancer Center
Des Moines, Iowa, United States
- Mercy Cancer Center at Mercy Medical Center - Des Moines
Des Moines, Iowa, United States
- Mercy Capitol Hospital
Des Moines, Iowa, United States
- Mccreery Cancer Center at Ottumwa Regional
Ottumwa, Iowa, United States
- Borgess Medical Center
Kalamazoo, Michigan, United States
- Bronson Methodist Hospital
Kalamazoo, Michigan, United States
- West Michigan Cancer Center
Kalamazoo, Michigan, United States
- Lakeland Regional Cancer Care Center - St. Joseph
Saint Joseph, Michigan, United States
- Ccop - Duluth
Duluth, Minnesota, United States
- Duluth Clinic Cancer Center - Duluth
Duluth, Minnesota, United States
- Miller - Dwan Medical Center
Duluth, Minnesota, United States
- Hutchinson Area Health Care
Hutchinson, Minnesota, United States
- Meeker County Memorial Hospital
Litchfield, Minnesota, United States
- Healtheast Cancer Care at St. John'S Hospital
Maplewood, Minnesota, United States
- Hennepin County Medical Center - Minneapolis
Minneapolis, Minnesota, United States
- Virginia Piper Cancer Institute at Abbott - Northwestern Hospital
Minneapolis, Minnesota, United States
- Healtheast Cancer Care at St. Joseph'S Hospital
Saint Paul, Minnesota, United States
- Regions Hospital Cancer Care Center
Saint Paul, Minnesota, United States
- St. Francis Cancer Center at St. Francis Medical Center
Shakopee, Minnesota, United States
- Healtheast Cancer Care at Woodwinds Health Campus
Woodbury, Minnesota, United States
- Cancer Resource Center - Lincoln
Lincoln, Nebraska, United States
- Ccop - Missouri Valley Cancer Consortium
Omaha, Nebraska, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 26 May 2004
- Primary completion
- 31 May 2011
- Completion
- 31 Aug 2012
- Last update posted
- 7 Jul 2023
- Registered enrollment
- 37
- Registry id
- NCT00062010
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.